{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:12:20Z","timestamp":1769929940264,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019260","name":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria","doi-asserted-by":"publisher","award":["34507\/2020"],"award-info":[{"award-number":["34507\/2020"]}],"id":[{"id":"10.13039\/501100019260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xphs.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T11:00:04Z","timestamp":1673866804000},"page":"1305-1314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1016","volume":"112","author":[{"given":"Mychelle Alves","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Cond\u00e9","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1976-5508","authenticated-orcid":false,"given":"Thiago Santana","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Silva","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Emanuelle Damazio","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-9883","authenticated-orcid":false,"given":"Anna Sophia Conhasco Lanzellotti","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5600-8667","authenticated-orcid":false,"given":"La\u00eds Oliveira dos Santos","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Nicolau","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Luiz do Nascimento","family":"Maranho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-5666","authenticated-orcid":false,"given":"Soraya de Mendon\u00e7a","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.01.005_bib0001","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jpba.2018.11.010","article-title":"NDMA impurity in valsartan and other pharmaceutical products: analytical methods for the determination of N-nitrosamines","volume":"164","author":"Parr","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2023.01.005_bib0002","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/carcin\/5.11.1381","article-title":"Relevance of nitrosamines to human cancer","volume":"5","author":"Bartsh","year":"1984","journal-title":"Carcinogeneses"},{"key":"10.1016\/j.xphs.2023.01.005_bib0003","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.etp.2014.07.002","article-title":"NDiethylnitrosamine mouse hepatotoxicity: time-related effects on histology and oxidative stress","volume":"66","author":"Santos","year":"2014","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.xphs.2023.01.005_bib0004","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.yrtph.2014.04.002","article-title":"Human health risk assessment of nitrosamines and nitramines for potential application in CO2 capture","volume":"69","author":"Ravnum","year":"2014","journal-title":"Regul Toxicol Pharm"},{"key":"10.1016\/j.xphs.2023.01.005_bib0005","article-title":"International Agency for Research on Cancer (IARC) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans - Some N-Nitroso Compounds","year":"1978","journal-title":"Lyon"},{"issue":"4","key":"10.1016\/j.xphs.2023.01.005_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0306-9877(94)90129-5","article-title":"Nitrosamine formation via non-prescription drugs?","volume":"42","author":"Nielsen","year":"1994","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.xphs.2023.01.005_bib0007","unstructured":"Foye WO, Sengupta SK. Em Principles of Medicinal Chemistry. eds.; Williams & Wilkins: Baltimore 2013: 747-780."},{"key":"10.1016\/j.xphs.2023.01.005_bib0008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jps.23760","article-title":"Analysis of sartans: a review","volume":"103","author":"Muszalska","year":"2014","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.xphs.2023.01.005_bib0009","unstructured":"U.S. Food & Drug Admnistration (FDA). Updates on valsartan recalls 2018. Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan. Accessed August 21, 2019."},{"issue":"10","key":"10.1016\/j.xphs.2023.01.005_bib0010","first-page":"1370","article-title":"Recall of NDMA-contaminated pseudo generic valsartan; best generics finally no better than others?","volume":"34","author":"Leclerc","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.xphs.2023.01.005_bib0011","unstructured":"ICH M7. International Council for Harmonisation. Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. Current Step 4 Version. 2014."},{"key":"10.1016\/j.xphs.2023.01.005_bib0012","unstructured":"ICH M7 (R1). International Council for Harmonisation. Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. Current Step 4 Version Dated March 31 2017."},{"key":"10.1016\/j.xphs.2023.01.005_bib0013","first-page":"22","article-title":"NDMA in valsartan","volume":"158","author":"Buschmann","year":"2018","journal-title":"Apoth"},{"key":"10.1016\/j.xphs.2023.01.005_bib0014","first-page":"1","article-title":"Noch Mehr nitrosamine","volume":"1-2","author":"Buschmann","year":"2019","journal-title":"DAZ"},{"key":"10.1016\/j.xphs.2023.01.005_bib0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpba.2019.04.035","article-title":"The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities","volume":"172","author":"Scherf-Clavel","year":"2019","journal-title":"J Pharmaceut Biomed Anal"},{"key":"10.1016\/j.xphs.2023.01.005_bib0016","unstructured":"ANVISA, Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Aprovado regulamento sobre nitrosaminas. 2019. Available at: http:\/\/portal.anvisa.gov.br\/noticias\/\/asset_publisher\/FXrpx9qY7FbU\/content\/aprovado-regulamento-sobre-nitrosaminas-\/219201. Accessed June 2019."},{"key":"10.1016\/j.xphs.2023.01.005_bib0017","unstructured":"BRAZIL, Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Resolu\u00e7\u00e3o da Diretoria Colegiada - RDC N\u00b0 677, 28\/04\/2022. Available at: https:\/\/www.in.gov.br\/en\/web\/dou\/-\/resolucao-rdc-n-677-de-28-de-abril-de-2022-397561756. Accessed May 2022."},{"key":"10.1016\/j.xphs.2023.01.005_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhazmat.2016.04.023","article-title":"LC\/QTOF-MS fragmentation of N-nitrosodimethylamine precursors in drinking water supplies is predictable and aids their identification","volume":"323","author":"Hanigan","year":"2017","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.xphs.2023.01.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2020.116096","article-title":"Seasonal occurrence of N-nitrosamines and their association with dissolved organic matter in full-scale drinking water systems: determination by LC-MS and EEM-PARAFAC","volume":"183","author":"Maqbool","year":"2020","journal-title":"Water Res"},{"key":"10.1016\/j.xphs.2023.01.005_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.chroma.2014.01.009","article-title":"Simultaneous determination of volatile and non-volatile nitrosamines in processed meat products by liquid chromatography tandem mass spectrometry using atmospheric pressure chemical ionisation and electrospray ionisation","volume":"1330","author":"Herrmann","year":"2014","journal-title":"J Chromatogr A"},{"issue":"8","key":"10.1016\/j.xphs.2023.01.005_bib0021","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3889\/oamjms.2019.261","article-title":"Analysis of nitrosamines in processed meat products in Medan city by liquid chromatography-mass spectrometry","volume":"7","author":"Cintya","year":"2019","journal-title":"Open Access Macedonian J Med Sci"},{"key":"10.1016\/j.xphs.2023.01.005_bib0022","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.scitotenv.2015.02.104","article-title":"Characterization of pharmaceuticals and personal care products in hospital effluent and waste water influent\/effluent by direct-injection LC-MS-MS","volume":"518-519","author":"Oliveira","year":"2015","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.xphs.2023.01.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2019.460465","article-title":"Stir bar sorptive-dispersive microextraction mediated by magnetic nanoparticles-metal organic framework composite: determination of N-nitrosamines in cosmetic products","volume":"1604","author":"Miralles","year":"2019","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.xphs.2023.01.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113460","article-title":"Determination of N-nitrosodimethylamine andN-nitrosomethylethylamine in drug substances and products ofsartans, metformin and ranitidine by precipitation and solid phaseextraction and gas chromatography\u2013tandem mass spectrometry","volume":"189","author":"Lim","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2023.01.005_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40543-020-00254-2","article-title":"Development of a sensitive and stable GC-MS\/MS method for simultaneous determination of four N-nitrosamine genotoxic impurities in sartan substances","volume":"12","author":"Liu","year":"2021","journal-title":"J Anal Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2023.01.005_bib0026","first-page":"31","article-title":"Screening of nitrosamine impurities in sartan pharmaceuticals by GC-MS\/MS","volume":"12","author":"Chang","year":"2021","journal-title":"Mass Spectrometry Lett"},{"key":"10.1016\/j.xphs.2023.01.005_bib0027","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/bkcs.12085","article-title":"Determination of N-nitrosodimethylamine and N-nitrosodiethylamine in sartans and metformin raw materials and finished products by headspace gas chromatography-tandem mass spectrometry","volume":"41","author":"Lim","year":"2020","journal-title":"Bull Korean Chem Soc"},{"issue":"16","key":"10.1016\/j.xphs.2023.01.005_bib0028","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1021\/acsomega.1c00982","article-title":"Development of a sensitive headspace gas chromatography\u2013mass spectrometry method for the simultaneous determination of nitrosamines in losartan active pharmaceutical ingredients","volume":"6","author":"Wichitnithad","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.xphs.2023.01.005_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-021-00669-8","article-title":"A full evaporation static headspace gas chromatography method with nitrogen phosphorous detection for ultrasensitive analysis of semi-volatile nitrosamines in pharmaceutical products","volume":"24","author":"Zheng","year":"2022","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2023.01.005_bib0030","first-page":"10","article-title":"A multi-analyte LC-MS\/MS method for screening and quantification of nitrosamines in sartans","volume":"28","author":"Chang","year":"2020","journal-title":"J Food Drug Anal"},{"issue":"3","key":"10.1016\/j.xphs.2023.01.005_bib0031","first-page":"541","article-title":"Development and validation of four nitrosamine impurities determination method in medicines of valsartan, losartan, and irbesartan with HPLC-MS\/MS (APCI)","volume":"20","author":"Khorolskiy","year":"2021","journal-title":"Iran J Pharm Res"},{"issue":"7","key":"10.1016\/j.xphs.2023.01.005_bib0032","doi-asserted-by":"crossref","first-page":"267","DOI":"10.56530\/lcgc.eu.dd3576s1","article-title":"Low-level determination of mutagenic nitrosamine impurities in drug substances by LC\u2013MS\/MS","volume":"34","author":"James","year":"2021","journal-title":"LCGC Eur"},{"key":"10.1016\/j.xphs.2023.01.005_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114561","article-title":"Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography\u2013tandem mass spectrometry","volume":"210","author":"Yamamoto","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2023.01.005_bib0034","unstructured":"The European Pharmacopoeia (Ph. Eur.). General chapter 2.5.42. N-Nitrosamines in active substances."},{"key":"10.1016\/j.xphs.2023.01.005_bib0035","unstructured":"BRAZIL. Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Resolu\u00e7\u00e3o da Diretoria Colegiada - RDC N\u00b0 166, 24\/07\/2017. Available at:http:\/\/antigo.anvisa.gov.br\/documents\/10181\/2721567\/RDC_166_2017_COMP.pdf\/d5fb92b3-6c6b-4130-8670-4e3263763401. Accessed May 2022."},{"key":"10.1016\/j.xphs.2023.01.005_bib0036","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.xphs.2023.01.005_bib0037","unstructured":"ICH - Validation of analytical procedures: text and methodology Q2(R1) 2005. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Available at: https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29%20Guideline.pdf. Accessed May 2022."},{"key":"10.1016\/j.xphs.2023.01.005_bib0038","unstructured":"Commission Decision 2002\/657\/EC. Commission decision of 12 august 2002 implementing council directive 96\/23\/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Commun. 2002;L221:8--36. Available at: https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/ed928116-a955-4a84-b10a-cf7a82bad858\/language-en. Accessed May 2022."},{"key":"10.1016\/j.xphs.2023.01.005_bib0039","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1038\/s41598-019-48344-5","article-title":"Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products","volume":"9","author":"Masada","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2023.01.005_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jaoacint\/qsab100","article-title":"Simultaneous estimation of six nitrosamine impurities in valsartan using liquid chromatographic method","volume":"105","author":"Bodiwala","year":"2022","journal-title":"J AOAC Int"},{"key":"10.1016\/j.xphs.2023.01.005_bib0041","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/elps.202000303","article-title":"Application of capillary electrophoresis-nano-electrosprayionization-mass spectrometry for the determination of N-nitrosodimethylamine in pharmaceuticals","volume":"42","author":"Rem\u00ednek","year":"2021","journal-title":"Electrophoresis"},{"key":"10.1016\/j.xphs.2023.01.005_bib0042","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2019.04.049","article-title":"Simultaneous detection of nitrosamines and other sartan-related impurities in active pharmaceutical ingredients by supercritical fluid chromatography","volume":"174","author":"Schmidtsdorff","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2023.01.005_bib0043","unstructured":"U.S. Food & Drug Admnistration (FDA). Method: \u201cLiquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) method for the determination of six nitrosamine impurities in ARB drugs\u201d 2019. Available at: https:\/\/www.fda.gov\/media\/125478\/download. Accessed May 2022."},{"key":"10.1016\/j.xphs.2023.01.005_bib0044","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpba.2019.05.022","article-title":"The contamination of valsartan and other sartans, part 1: new findings","volume":"172","author":"S\u00f6rgel","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2023.01.005_bib0045","unstructured":"The United State Pharmacopeia. 2022. USP-NF \u30081469\u3009 nitrosamine impurities. Available at: https:\/\/online.uspnf.com\/uspnf\/document\/1_GUID-C97F817C-A383-4693-8E0C-2F0A0A371977_2_en-US. Accessed June 2022."}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:40:14Z","timestamp":1758361214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0022354923000060"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.01.005","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}